首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of huntingtons disease

缩写:

ISSN:1879-6397

e-ISSN:1879-6400

IF/分区:2.7/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引492
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Ray Truant,Rachel J Harding,Kaitlyn Neuman et al. Ray Truant et al.
Protein localization signals and activity motifs have been defined within huntingtin since 2003. Advances in technology in protein structure determination by cryo-electron microscopy (EM) have led to 2.6 Å resolution structures of huntingt...
Jennifer Petrillo,A Alex Levine,Jason Johannesen et al. Jennifer Petrillo et al.
Background: Cognitive impairment in Huntington's disease (HD) is a key driver of disability that can have deleterious impacts on everyday functioning. Currently available patient-reported outcome measures may not adequate...
Lauren E Tueth,Allison M Haussler,Sidney T Baudendistel et al. Lauren E Tueth et al.
Background: Individuals with Huntington's disease (HD) experience a variety of motor and non-motor symptoms, but little is known about how these symptoms are related to one another. It is important to characterize the def...
Mena Farag,Sarah J Tabrizi,Edward J Wild Mena Farag
In this edition of the Huntington's Disease Clinical Trials Update, we expand on the ongoing extension study of PTC518 from PTC Therapeutics, including 12-month interim results from the parent study. We also discuss 24-month interim results...
Marie Caillaud,Mickael Laisney,Alexandre Bejanin et al. Marie Caillaud et al.
Background: Huntington's disease (HD) is traditionally associated with motor, cognitive, and neuropsychiatric symptoms. Recent observations suggest that disturbances in social cognition may feature prominently in HD, pote...
Cesa Scaglione,Maria Vitiello,Lorenzo Tonetti et al. Cesa Scaglione et al.
Background: Disrupted 24-h sleep-wake and rest-activity cycles are known common features in Huntington's disease (HD) patients; however, critical periods during the 24-h cycle have been less studied. Objective: To analyze the differences be...
Sandra Bartolomeu Pires,Dorit Kunkel,Nicholas Goodwin et al. Sandra Bartolomeu Pires et al.
Background: Huntington's disease (HD) is among the most complex long-term neurological conditions, necessitating care and management from multiple partners within and beyond the health sector. However, there is a paucity of evidence describ...
Vinod Khetarpal,Todd Herbst,Celia Dominguez et al. Vinod Khetarpal et al.
Background: Evidence from animal studies and post-mortem studies of brains from people with Huntington's disease (PwHD) has suggested that the kynurenine pathway (KP) may be dysregulated in Huntington's disease (HD). ...
Jared T Hinkle,Erin Wildermuth,Xiao J Tong et al. Jared T Hinkle et al.
Background: Anosognosia, or unawareness of symptoms, is common in Huntington's disease (HD), but the neuroanatomical basis of this is unknown. Objective: ...
Sarah M Gray,Jing Dai,Anne C Smith et al. Sarah M Gray et al.
Background: There is evidence for dysregulated cholesterol homeostasis in Huntington's disease (HD). The brain-specific cholesterol metabolite 24(S)-hydroxycholesterol (24(S)-OHC) is decreased in manifest HD. 24(S)-OHC is...